グローバルにおける女性医療(リプロダクティブ・ヘルス)市場(2014-2018)...市場調査レポートについてご紹介

【英文タイトル】Global Women's Health Market 2014-2018

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Application
07.1.1 Postmenopausal Osteoporosis
07.1.2 Hormonal Contraceptives
07.1.3 Menopause
07.1.4 Infertility
07.1.5 Endometriosis
07.1.6 Polycystic Ovary Syndrome
08. Global Postmenopausal Osteoporosis Market
08.1 Market Overview
08.2 Market Size and Forecast
09. Global Hormonal Contraceptives Market
09.1 Market Overview
09.2 Market Size and Forecast
10. Global Menopause Market
10.1 Market Overview
10.2 Market Size and Forecast
11. Global Infertility Market
11.1 Market Overview
11.2 Market Size and Forecast
12. Global Endometriosis Market
12.1 Market Overview
12.2 Market Size and Forecast
13. Global Polycystic Ovary Syndrome Market
13.1 Market Overview
13.2 Market Size and Forecast
14. Geographical Segmentation
15. Buying Criteria
16. Market Growth Drivers
17. Drivers and their Impact
18. Market Challenges
19. Impact of Drivers and Challenges
20. Market Trends
21. Trends and their Impact
22. Vendor Landscape
22.1 Competitive Scenario
22.1.1 Key News
22.1.2 Mergers and Acquisitions
22.2 Market Share Analysis 2013
22.2.1 Sales of Major Women’s Health Products 2013
22.3 Other Prominent Vendors
23. Key Vendor Analysis
23.1 Actavis plc
23.1.1 Key Facts
23.1.2 Business Description
23.1.3 Business Segmentation
23.1.4 Business Segmentation by Revenue 2012 and 2013
23.1.5 Sales by Geography
23.1.6 Business Strategy
23.1.7 Key Information
23.1.8 SWOT Analysis
23.1.9 Strengths
23.1.10 Weaknesses
23.1.11 Opportunities
23.1.12 Threats
23.2 Bayer AG
23.2.1 Key Facts
23.2.2 Business Overview
23.2.3 Business Segmentation
23.2.4 Business Segmentation by Revenue 2012 and 2013
23.2.5 Sales by Geography
23.2.6 Business Strategy
23.2.7 Key Information
23.2.8 SWOT Analysis
23.2.9 Strengths
23.2.10 Weaknesses
23.2.11 Opportunities
23.2.12 Threats
23.3 Eli Lilly and Co.
23.3.1 Key Facts
23.3.2 Business Overview
23.3.3 Business Segmentation by Revenue 2013
23.3.4 Business Segmentation by Revenue 2012 and 2013
23.3.5 Sales by Geography
23.3.6 Business Strategy
23.3.7 Key Developments
23.3.8 SWOT Analysis
23.3.9 Strengths
23.3.10 Weaknesses
23.3.11 Opportunities
23.3.12 Threats
23.4 Merck & Co. Inc.
23.4.1 Key Facts
23.4.2 Business Overview
23.4.3 Business Segmentation by Revenue 2013
23.4.4 Business Segmentation by Revenue 2012 and 2013
23.4.5 Sales by Geography
23.4.6 Business Strategy
23.4.7 Key Developments
23.4.8 SWOT Analysis
23.4.9 Strengths
23.4.10 Weaknesses
23.4.11 Opportunities
23.4.12 Threats
23.5 Pfizer Inc.
23.5.1 Key Facts
23.5.2 Business Overview
23.5.3 Business Segmentation by Revenue 2013
23.5.4 Business Segmentation by Revenue 2012 and 2013
23.5.5 Sales by Geography
23.5.6 Business Strategy
23.5.7 Key Developments
23.5.8 SWOT Analysis
23.5.9 Strengths
23.5.10 Weaknesses
23.5.11 Opportunities
23.5.12 Threats
24. Other Reports in this Series

List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Women’s Health Market 2013-2018 (US$ million)
Exhibit 3: List of Products for Women’s Health Served by Other Prominent Players
Exhibit 4: Global Women’s Health Market Segmentation by Application
Exhibit 5: Global Women’s Health Market Segmentation by Application 2013
Exhibit 6: Global Women’s Health Market Segmentation by Application 2013-2018 (in percent)
Exhibit 7: Global Women’s Health Market Segmentation by Application 2013-2018 (US$ million)
Exhibit 8: Global Postmenopausal Osteoporosis Market 2013-2018 (US$ million)
Exhibit 9: Global Hormonal Contraceptives Market 2013-2018 (US$ million)
Exhibit 10: Global Menopause Market 2013-2018 (US$ million)
Exhibit 11: Global Infertility Market 2013-2018 (US$ million)
Exhibit 12: Global Endometriosis Market 2013-2018 (US$ million)
Exhibit 13: Global Polycystic Ovary Syndrome Market 2013-2018 (US$ million)
Exhibit 14: Global Women’s Health Market by Geographical Segmentation
Exhibit 15: Global Women’s Health market Business Segmentation 2013
Exhibit 16: Global Women’s Health market Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 17: Actavis Plc: Sales by Geography (in US$ million)
Exhibit 18: Bayer AG: Business Segmentation 2013
Exhibit 19: Bayer AG: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 20: Bayer AG: Sales by Geography 2013
Exhibit 21: Eli Lilly and Co.: Business Segmentation by Revenue 2013
Exhibit 22: Eli Lilly and Co.: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 23: Eli Lilly and Co.: Sales by Geography 2013
Exhibit 24: Merck & Co. Inc.: Business Segmentation by Revenue 2013
Exhibit 25: Merck & Co. Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 26: Merck & Co. Inc.: Sales by Geography 2013
Exhibit 27: Pfizer Inc.: Business Segmentation by Revenue 2013
Exhibit 28: Pfizer Inc.: Business Segmentation by Revenue 2012 and 2013
Exhibit 29: Pfizer Inc.: Sales by Geography 2013


【レポート販売概要】

■ タイトル:グローバルにおける女性医療(リプロダクティブ・ヘルス)市場(2014-2018)
■ 英文:Global Women's Health Market 2014-2018
■ 発行日:2014年7月7日
■ 調査会社:Technavio
■ 商品コード:IRTNTR3774
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。